Ethnopharmacological survey of medicinal plants used by patients with psoriasis in the West Bank of Palestine

BMC Complementary and Alternative Medicine

Volumn 17, Issue 1, 2017, Pages

  Shawahna, Ramzi ^a   Jaradat, Nidal Amin ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

CAM; Ethnopharmacology; Medicinal plants; Palestine; Psoriasis

Indexed keywords

HERBACEOUS AGENT; PLANT EXTRACT;

ADULT; AGE; ALMOND; ALOE VERA; ALTERNATIVE MEDICINE; ANTHEMIS COTULA; ARTICLE; AVENA BARBATA; AVOCADO; CAPSICUM ANNUUM; CATHARANTHUS ROSEUS; CROSS-SECTIONAL STUDY; CURCUMA LONGA; DRUG USE; DRY SKIN; ERYTHEMA; ETHNOPHARMACOLOGY; FIG; FRUIT; GLYCYRRHIZA GLABRA; HOUSEHOLD INCOME; HUMAN; IMMUNOMODULATION; INTERVIEW; JUGLANS REGIA; LAMIACEAE; LEGUME; LINSEED; MAJOR CLINICAL STUDY; MEDICINAL PLANT; NIGELLA ARVENSIS; OLIVE TREE; OUTPATIENT; PALESTINE; PASTE; PINUS HALEPENSIS; PLANT LEAF; PSORIASIS; QUESTIONNAIRE; SELF REPORT; SIMMONDSIA CHINENSIS; SKIN FISSURE; TRIGONELLA ARABICA; URTICARIA; AGED; CHEMISTRY; CLASSIFICATION; FEMALE; MALE; MIDDLE AGED; MIDDLE EAST; PHYTOTHERAPY; YOUNG ADULT;

ADULT; AGED; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; ETHNOPHARMACOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PSORIASIS; YOUNG ADULT;

EID: 85008163172     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1503-4     Document Type: Article

References (48)

1. Tse WP, Che CT, Liu K, Lin ZX. Evaluation of the anti-proliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells. J Ethnopharmacol. 2006;108(1):133-41.
2. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest. 2004;113(12):1664-75.
3. Ammar-Khodja A, Benkaidali I, Bouadjar B, Serradj A, Titi A, Benchikhi H, Amal S, Hassam B, Sekkat A, Mernissi FZ, et al. EPIMAG: International Cross-Sectional Epidemiological Psoriasis Study in the Maghreb. Dermatology. 2015;231(2):134-44.
4. Fleischer Jr AB, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR, Rajashekhar V. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol. 1996;107(1):26-9.
5. Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G, et al. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49(5):897-9.
6. Rich SJ, Bello-Quintero CE. Advancements in the treatment of psoriasis: role of biologic agents. J Manag Care Pharm. 2004;10(4):318-25.
7. Beyer V, Wolverton SE. Recent trends in systemic psoriasis treatment costs. Arch Dermatol. 2010;146(1):46-54.
8. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57(6):957-62.
9. Patel V, Horn EJ, Lobosco SJ, Fox KM, Stevens SR, Lebwohl M. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists. J Am Acad Dermatol. 2008;58(6):964-9.
10. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140(4):408-14.
11. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001;45(5):649-61. quiz 62-4.
12. Griffiths CE, Richards HL. Psychological influences in psoriasis. Clin Exp Dermatol. 2001;26(4):338-42.
13. Jaradat NA, Shawahna R, Eid AM, Al-Ramahi R, Asma MK, Zaid AN. Herbal remedies use by breast cancer patients in the West Bank of Palestine. J Ethnopharmacol. 2016;178:1-8.
14. Dalaker M, Jacobsen T, Lysvand H, Iversen OJ. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by cyclosporin A. Acta Derm Venereol. 1999;79(4):281-4.
15. Smith N, Weymann A, Tausk FA, Gelfand JM. Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. J Am Acad Dermatol. 2009;61(5):841-56.
16. Damevska K, Neloska L, Nikolovska S, Gocev G, Duma S. Complementary and alternative medicine use among patients with psoriasis. Dermatol Ther. 2014;27(5):281-3.
17. Ben-Arye E, Ziv M, Frenkel M, Lavi I, Rosenman D. Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine. Dermatology. 2003;207(3):302-7.
18. Bauml JM, Chokshi S, Schapira MM, Im EO, Li SQ, Langer CJ, Ibrahim SA, Mao JJ. Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer. 2015;121(14):2431-8.
19. Bauml J, Langer CJ, Evans T, Garland SN, Desai K, Mao JJ. Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Support Care Cancer. 2014;22(9):2465-72.
20. Fleischer Jr AB, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR. Alternative therapies commonly used within a population of patients with psoriasis. Cutis. 1996;58(3):216-20.
21. Baron SE, Goodwin RG, Nicolau N, Blackford S, Goulden V. Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom. J Am Acad Dermatol. 2005;52(4):589-94.
22. Chen YF, Chang JS. Complementary and alternative medicine use among patients attending a hospital dermatology clinic in Taiwan. Int J Dermatol. 2003;42(8):616-21.
23. Clark CM, McKay RA, Fortune DG, Griffiths CE. Use of alternative treatments by patients with psoriasis. Br J Gen Pract. 1998;48(437):1873-4.
24. Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health. 1996;1(4):505-9.
25. Paulsen E, Korsholm L, Brandrup F. A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2005;19(3):326-31.
26. Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, Akhter S, Kazmi I, Jyoti, Ahmad FJ, Anwar F. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets. 2012;12(3):287-302.
27. Matsuda H, Tewtrakul S, Morikawa T, Nakamura A, Yoshikawa M. Anti-allergic principles from Thai zedoary: structural requirements of curcuminoids for inhibition of degranulation and effect on the release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem. 2004;12(22):5891-8.
28. Heng MC, Song MK, Harker J, Heng MK. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol. 2000;143(5):937-49.
29. Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY, Surh YJ. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene. 2005;24(15):2558-67.
30. Man MQ, Shi Y, Man M, Lee SH, Demerjian M, Chang S, Feingold KR, Elias PM. Chinese herbal medicine (Tuhuai extract) exhibits topical anti-proliferative and anti-inflammatory activity in murine disease models. Exp Dermatol. 2008;17(8):681-7.
31. Sampson JH, Raman A, Karlsen G, Navsaria H, Leigh IM. In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. Phytomedicine. 2001;8(3):230-5.
32. Puri D, Prabhu K, Murthy P. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol. 2002;46(4):457-62.
33. Stucker M, Memmel U, Hoffmann M, Hartung J, Altmeyer P. Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. Dermatology. 2001;203(2):141-7.
34. Mabona U, Viljoen A, Shikanga E, Marston A, Van Vuuren S. Antimicrobial activity of southern African medicinal plants with dermatological relevance: from an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound. J Ethnopharmacol. 2013;148(1):45-55.
35. Keseroglu H, Gönül M, Kurmus G. Prevalence of herbal therapy usage in patients with psoriasis in Turkey. TANG. 2015;5(2):48-52.
36. Jamal Z, Ahmad MZ, Zafar M, Sultana S, Khan M, Shah G. Medicinal plants used in traditional folk recipes by the local communities of Kaghan valley, Mansehra, Pakistan. Indian J Tradit Know. 2012;11:634-9.
37. Rajeswari R, Umadevi M, Rahale C, Pushpa R, Selvavenkadesh S, Kumar K, Bhowmik D. Aloe vera: the miracle plant its medicinal and traditional uses in India. J Pharmacogn Phytochem. 2012;1(4):118-24.
38. Oumeish Y. Traditional Arabic medicine in dermatology. Clin Dermatol. 1999;17(1):13-20.
39. Jaradat NA. Ethnopharmacological survey of natural products in palestine. An-Najah Univ J Res. 2005;19:13-67.
40. Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel S, Herrera-Ruiz D, Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol. 2008;227(1):125-35.
41. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P. A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol. 2010;24(2):168-72.
42. Dhanabal S, Priyanka Dwarampudi L, Muruganantham N, Vadivelan R. Evaluation of the antipsoriatic activity of Aloe vera leaf extract using a mouse tail model of psoriasis. Phytother Res. 2012;26(4):617-9.
43. Morrow D, Rapaport M, Strick R. Hypersensitivity to aloe. Arch Dermatol. 1980;116(9):1064-5.
44. Graf J. Herbal anti-inflammatory agents for skin disease. Skin Therapy Lett. 2000;5(4):3-5.
45. Jaradat NA. Medical plants utilized in Palestinian folk medicine for treatment of diabetes mellitus and cardiac diseases. J Al-Aqsa Unv. 2005;9:1-28.
46. Huma A, Rizwani G, Usman M, Ishaque S, Ansari S, Anwer S. Drug development of herbomineral capsule (ALG-06) used for hypopigmentation specially in vitiligo. Pak J Pharm Sci. 2014;27(5 Spec No):1451-7.
47. Pattarachotanant N, Rakkhitawatthana V, Tencomnao T. Effect of Gloriosa superba and Catharanthus roseus Extracts on IFN-γ-Induced Keratin 17 Expression in HaCaT Human Keratinocytes. Evid Based Complement Alternat Med. 2014;2014:249367.
48. Paulsen E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis. 2002;47(4):189-98.